{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:15:24Z","timestamp":1790302524478,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[1998,12]]},"DOI":"10.1124\/mol.54.6.1140","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T20:32:14Z","timestamp":1515443534000},"page":"1140-1147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"title":["Cycloguanil and Its Parent Compound Proguanil Demonstrate Distinct Activities against Plasmodium falciparumMalaria Parasites Transformed with Human Dihydrofolate Reductase"],"prefix":"10.1016","volume":"54","author":[{"given":"David A.","family":"Fidock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Wellems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.54.6.1140_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0166-6851(94)00207-4","article-title":"Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum.","volume":"69","author":"Basco","year":"1995","journal-title":"Mol Biochem Parasitol"},{"key":"10.1124\/mol.54.6.1140_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0035-9203(94)90233-X","article-title":"Multiresistant falciparum malaria cured using atovaquone and proguanil.","volume":"88","author":"Blanchard","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1124\/mol.54.6.1140_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0166-6851(96)02704-1","article-title":"Recombinant Plasmodium falciparum dihydrofolate reductase-based in vitro screen for antifolate antimalarials.","volume":"81","author":"Brobey","year":"1996","journal-title":"Mol Biochem Parasitol"},{"key":"10.1124\/mol.54.6.1140_bib4","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1128\/AAC.40.9.2067","article-title":"Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.","volume":"40","author":"Brun-Pascaud","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.54.6.1140_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4269\/ajtmh.1993.49.121","article-title":"PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists.","volume":"49","author":"Canfield","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"10.1124\/mol.54.6.1140_bib6","doi-asserted-by":"crossref","first-page":"9109","DOI":"10.1073\/pnas.85.23.9109","article-title":"Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum.","volume":"85","author":"Cowman","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.54.6.1140_bib7","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1073\/pnas.93.14.7289","article-title":"Characterization of promoters and stable transfection by homologous and nonhomologous recombination in Plasmodium falciparum.","volume":"93","author":"Crabb","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.54.6.1140_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0166-6851(97)00143-6","article-title":"Stable transgene expression in Plasmodium falciparum.","volume":"90","author":"Crabb","year":"1997","journal-title":"Mol Biochem Parasitol"},{"key":"10.1124\/mol.54.6.1140_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0026-895X(25)14644-0","article-title":"Plasmodium berghei dihydrofolate reductase: isolation, properties and inhibition by antifolates.","volume":"5","author":"Ferone","year":"1969","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.54.6.1140_bib10","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1073\/pnas.94.20.10931","article-title":"Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.","volume":"94","author":"Fidock","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.54.6.1140_bib11","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1073\/pnas.87.8.3014","article-title":"Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.","volume":"87","author":"Foote","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.54.6.1140_bib12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/expr.1997.4156","article-title":"Plasmodium falciparum: a simple, rapid method for detecting parasite clones in microtiter plates.","volume":"86","author":"Goodyer","year":"1997","journal-title":"Exp Parasitol"},{"key":"10.1124\/mol.54.6.1140_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0065-2571(94)90025-6","article-title":"The methotrexate story: a paradigm for development of cancer chemotherapeutic agents.","volume":"34","author":"Huennekens","year":"1994","journal-title":"Adv Enzyme Regul"},{"key":"10.1124\/mol.54.6.1140_bib14","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1128\/AAC.37.7.1417","article-title":"Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist.","volume":"37","author":"Hughes","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.54.6.1140_bib15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(97)09222-2","article-title":"Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children.","volume":"351","author":"Lell","year":"1998","journal-title":"Lancet"},{"key":"10.1124\/mol.54.6.1140_bib16","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1074\/jbc.270.10.5057","article-title":"Methotrexate-resistant variants of human dihydrofolate reductase with substitutions of leucine 22: kinetics, crystallography, and potential as selectable markers.","volume":"270","author":"Lewis","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.54.6.1140_bib17","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0140-6736(95)12333-4","article-title":"Antiretroviral drugs for AIDS.","volume":"348","author":"Lipsky","year":"1996","journal-title":"Lancet"},{"key":"10.1124\/mol.54.6.1140_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4269\/ajtmh.1996.54.62","article-title":"Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand.","volume":"54","author":"Looareesuwan","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.1124\/mol.54.6.1140_bib19","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/0035-9203(95)90434-4","article-title":"Japanese poor metabolizers of proguanil do not have an increased risk of malaria chemoprophylaxis breakthrough.","volume":"89","author":"Mberu","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1124\/mol.54.6.1140_bib20","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1128\/AAC.39.8.1862","article-title":"In vitro activities of PS-15, a new dihydrofolate reductase inhibitor, and its cyclic metabolite against Mycobacterium avium complex.","volume":"39","author":"Meyer","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/mol.54.6.1140_bib21","first-page":"6","article-title":"Malaria chemosuppression in pregnancy. I. The effect of chemosuppressive drugs on maternal parasitaemia.","volume":"45","author":"Mutabingwa","year":"1993","journal-title":"Trop Geogr Med"},{"key":"10.1124\/mol.54.6.1140_bib22","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1073\/pnas.87.8.3018","article-title":"Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.","volume":"87","author":"Peterson","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.54.6.1140_bib23","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","article-title":"Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria.","volume":"85","author":"Peterson","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.54.6.1140_bib24","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1086\/514159","article-title":"Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.","volume":"176","author":"Plowe","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1124\/mol.54.6.1140_bib25","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(96)90671-6","article-title":"Atovaquone and proguanil for Plasmodium falciparum malaria.","volume":"347","author":"Radloff","year":"1996","journal-title":"Lancet"},{"key":"10.1124\/mol.54.6.1140_bib26","doi-asserted-by":"crossref","unstructured":"Reichman LB (1996) Multidrug resistance in the world: the present situation. Chemotherapy 42(Suppl 3):2\u20139.","DOI":"10.1159\/000239506"},{"key":"10.1124\/mol.54.6.1140_bib27","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1074\/jbc.273.6.3461","article-title":"A biochemical and genetic model for parasite resistance to antifolates: Toxoplasma gondii provides insights into pyrimethamine and cycloguanil resistance in Plasmodium falciparum.","volume":"273","author":"Reynolds","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.54.6.1140_bib28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0035-9203(57)90036-6","article-title":"Experiments with antimalarial drugs in man. V. Experiments with an active metabolite of proguanil and an active metabolite of 5943.","volume":"51","author":"Robertson","year":"1957","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1124\/mol.54.6.1140_bib29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3181\/00379727-80-19625","article-title":"Antimalarial activities of triazine metabolites of chlorguanide and di-chlorguanide.","volume":"80","author":"Schmidt","year":"1952","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1124\/mol.54.6.1140_bib30","doi-asserted-by":"crossref","first-page":"21637","DOI":"10.1016\/S0021-9258(20)80589-4","article-title":"The dihydrofolate reductase domain of Plasmodium falciparum thymidylate synthase-dihydrofolate reductase: gene synthesis, expression, and anti-folate-resistant mutants.","volume":"268","author":"Sirawaraporn","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.54.6.1140_bib31","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1073\/pnas.94.4.1124","article-title":"Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase.","volume":"94","author":"Sirawaraporn","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.54.6.1140_bib32","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4269\/ajtmh.1961.10.694","article-title":"Antimalarial activity and metabolism of biguanides. I. Metabolism of chlorguanide and chlorguanide triazine in rhesus monkeys in man.","volume":"10","author":"Smith","year":"1961","journal-title":"Am J Trop Med Hyg"},{"key":"10.1124\/mol.54.6.1140_bib33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1006\/bbrc.1997.6814","article-title":"Lead discovery of inhibitors of the dihydrofolate reductase domain of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase.","volume":"235","author":"Toyoda","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.54.6.1140_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0166-6851(97)00114-X","article-title":"Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins.","volume":"89","author":"Wang","year":"1997","journal-title":"Mol Biochem Parasitol"},{"key":"10.1124\/mol.54.6.1140_bib35","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1365-2125.1989.tb03440.x","article-title":"Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.","volume":"27","author":"Ward","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/mol.54.6.1140_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/00034983.1984.11811816","article-title":"The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro.","volume":"78","author":"Watkins","year":"1984","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1124\/mol.54.6.1140_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0166-6851(96)02808-3","article-title":"Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum.","volume":"85","author":"Wooden","year":"1997","journal-title":"Mol Biochem Parasitol"},{"key":"10.1124\/mol.54.6.1140_bib38","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1073\/pnas.93.3.1130","article-title":"Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine.","volume":"93","author":"Wu","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.54.6.1140_bib39","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1073\/pnas.92.4.973","article-title":"Transfection of Plasmodium falciparum within human red blood cells.","volume":"92","author":"Wu","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.54.6.1140_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/00034983.1997.11813107","article-title":"Effects of folic and folinic acids in the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic culture.","volume":"91","author":"Yeo","year":"1997","journal-title":"Ann Trop Med Parasitol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24130386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24130386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.54.6.1140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T09:56:41Z","timestamp":1740045401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24130386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["S0026895X24130386"],"URL":"https:\/\/doi.org\/10.1124\/mol.54.6.1140","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[1998,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cycloguanil and Its Parent Compound Proguanil Demonstrate Distinct Activities against Plasmodium falciparumMalaria Parasites Transformed with Human Dihydrofolate Reductase","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.54.6.1140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 1998 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}